Cantor Fitzgerald Forecasts NTLA FY2025 Earnings
Intellia Therapeutics, Inc. (NASDAQ:NTLA – Free Report) – Cantor Fitzgerald issued their FY2025 EPS estimates for Intellia Therapeutics in a research report issued on Monday, March 17th. Cantor Fitzgerald analyst R. Bienkowski anticipates that the company will earn ($4.34) per share for the year. The consensus estimate for Intellia Therapeutics’ current full-year earnings is ($5.07) […]
Intellia Therapeutics, Inc. (NASDAQ:NTLA – Free Report) – Cantor Fitzgerald issued their FY2025 EPS estimates for Intellia Therapeutics in a research report issued on Monday, March 17th. Cantor Fitzgerald analyst R. Bienkowski anticipates that the company will earn ($4.34) per share for the year. The consensus estimate for Intellia Therapeutics’ current full-year earnings is ($5.07) […]
